XML 12 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 8,134,004 $ 13,159,423
Prepaid assets and other current assets 385,444 483,996
Total current assets 8,519,448 13,643,419
Deferred offering costs and other assets 391,838 392,491
Total assets 8,911,286 14,035,910
Current liabilities:    
Accounts payable 1,201,393 1,524,190
Other accrued expenses 2,602,611 3,567,404
Accrued compensation 885,813 588,304
Accrued interest, current 32,080 27,018
Total current liabilities 4,721,897 5,706,916
Long term liabilities:    
License payable 404,991 404,991
Total long-term liabilities 404,991 404,991
Total liabilities 5,126,888 6,111,907
Commitments and contingencies (Note 4)
Stockholders’ equity:    
Preferred stock, $0.000001 par value, 10,000,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.000001 par value, 200,000,000 shares authorized, 23,711,677 and 23,245,203 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively, 24 23
Additional paid-in capital 164,017,824 162,531,681
Accumulated deficit (160,233,450) (154,607,701)
Total stockholders’ equity 3,784,398 7,924,003
Total liabilities and stockholders’ equity $ 8,911,286 $ 14,035,910